Due to inhibition of targets in part that do not necessarily involved VEGF/VEGFR signaling, VEGFR inhibitors frequently induce toxicities such as hypertension, fatigue, delayed wound healing [3, 39]. This evidence concerns the gene KDR and hypertensive disorder.